AzTrials
AzTrials

Emergency SurgeryNCT06501170

Risk Stratification for Abdominal Emergency Surgery: a Cohort Study

An observational study of Emergency Surgery, run by Peking Union Medical College Hospital at 1 site in China.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this retrospective observational study is to identify risk factors of unwanted outcomes (in-hospital morbidity and mortality) among patients undergoing emergency abdominal surgery. Read more about this study

Who is it for?
Any age
Conditions the study is for
Emergency Surgery
What is being tested?
Retrospective Data Analysis of Emergency Abdominal Surgery Outcomes
How many people
1,000 participants
Where
1 siteChina
Study dates
1 Jun 2024to 1 Jun 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients undergoing emergency abdominal surgery at a single tertiary care institution between January 1, 2023, and June 1, 2024.

Who may be able to join

  • Patients undergoing emergency abdominal surgery at a single tertiary care institution between January 1, 2023, and June 1, 2024

Who cannot join

  • Repeated surgery for the same patients

Trial locations and contacts

1 site in 1 country.

China1 site
  • Lu Che

    Beijing, Beijing Municipality, 100073

Other trials in China

About this study

Official title: Risk Factors of Adverse Outcomes After Emergency Abdominal Emergency Surgery and Establishment of a Risk Stratification Tool

The goal of this retrospective observational study is to identify risk factors of unwanted outcomes (in-hospital morbidity and mortality) among patients undergoing emergency abdominal surgery.

Read the detailed description

Patients undergoing emergency abdominal surgery at a single tertiary care institution with a high volume of emergency abdominal surgeries, especially for high-acuity patients, between January 1, 2023, and June 1, 2024, will be included. Baseline demographics, indication for surgery, and preoperative status (respiratory support, cardiovascular stability, Glasgow score, SOFA score, preoperative lab results, and preoperative waiting time including Time to Theatre (TTT) and Time to Knife (TTK)) will be recorded.

Definitions:

Time to Theatre (TTT): The duration from when it is determined that the patient needs surgery to the time the patient arrives at the operating theatre.

Time to Knife (TTK): The duration from when the patient enters the operating theatre to the time the first incision is made.

These data will be retrieved from the electronic health record system.

Intraoperative factors, including ASA classification, anesthesia method, type of surgical intervention, intraoperative lab results, transfusions, input/output (I/O), inotropic/vasopressor usage, and discharge ward, will also be retrieved from the electronic health record system. Postoperative outcomes, including in-hospital mortality and morbidity (complications stratified by the Clavien-Dindo classification system), will be assessed by trained investigators. Secondary outcomes include postoperative length of hospital stay and health care costs.

A statistical model will be built to identify risk factors for morbidity and mortality.

Being tested
Retrospective Data Analysis of Emergency Abdominal Surgery Outcomes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Retrospective Data Analysis of Emergency Abdominal Surgery OutcomesOther

    Retrospective Data Analysis of Emergency Abdominal Surgery Outcomes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. in-hospital mortality

    documented in-hospital mortality

    Measured: From date of surgery until discharge day, assessed up to 4 weeks

  2. in-hospital morbidity

    in-hospital postoperative complications classified using Clavein-Dindo score

    Measured: From date of surgery until discharge day, assessed up to 4 weeks

Secondary outcomes (2)
  1. postoperative length of hospital stay

    postoperative length of hospital stay assessed by days

    Measured: From date of surgery until discharge day, assessed up to 4 weeks

  2. Health care costs

    Health care costs in RMB assessed using hospital billing records

    Measured: From date of admission until discharge day, assessed up to 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2024
  2. Study start1 Jun 2024
  3. Primary completion27 Feb 2025
  4. Study completion1 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06501170
Sponsor's protocol ID
K6243
Status last verified
Feb 2025
First submitted
26 Jun 2024
Last updated
7 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Surgery, run by Peking Union Medical College Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

in-hospital mortality (time frame: From date of surgery until discharge day, assessed up to 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in